TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
NeuroGyn Norr AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
458
|
974
|
1,414 |
Financial expenses |
98
|
78
|
102 |
Earnings before taxes |
-222
|
-228
|
49 |
EBITDA |
-124
|
-145
|
154 |
Total assets |
445
|
658
|
969 |
Current assets |
353
|
525
|
819 |
Current liabilities |
335
|
495
|
472 |
Equity capital |
109
|
162
|
480 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
24.5%
|
24.6%
|
49.5% |
Turnover per employee |
458
|
487
|
707 |
Profit as a percentage of turnover |
-48.5%
|
-23.4%
|
3.5% |
Return on assets (ROA) |
-27.9%
|
-22.8%
|
15.6% |
Current ratio |
105.4%
|
106.1%
|
173.5% |
Return on equity (ROE) |
-203.7%
|
-140.7%
|
10.2% |
Change turnover |
-521
|
-326
|
-125 |
Change turnover % |
-53%
|
-25%
|
-8% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.